Provided by Tiger Fintech (Singapore) Pte. Ltd.

BAIYUNSHAN PH

18.580
-0.050-0.27%
Volume:274.00K
Turnover:5.09M
Market Cap:30.21B
PE:9.74
High:18.620
Open:18.580
Low:18.480
Close:18.630
52wk High:22.348
52wk Low:15.014
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:0.84
T/O Rate:0.12%
Dividend:0.87
Dividend Rate:4.71%
EPS(LYR):1.907
ROE:7.46%
ROA:2.60%
PB:0.73
PE(LYR):9.74
PS:0.36

Loading ...

Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH): Ceftazidime for Injection Passes Generic Drug Consistency Evaluation

Stock News
·
Sep 03

Baiyunshan Pharma Gets Nod to Make Amendments to Two Antibiotics

MT Newswires Live
·
Sep 02

BAIYUNSHAN PH (00874): Subsidiary Baiyunshan Hanfang Receives Marketing Authorization for Structured Triglycerides Chemical Raw Material

Stock News
·
Aug 29

BAIYUNSHAN PH (00874): Guangzhou Pharmaceutical Sells Fourth Batch of Additional Basic Assets to Xingzheng Asset Management

Stock News
·
Aug 28

Guangzhou Baiyunshan Pharmaceutical - Disposals of Accounts Receivable

THOMSON REUTERS
·
Aug 28

Guangzhou Baiyunshan Pharmaceutical - Confirm Disposal of Fourth New Underlying Assets of Gp Corp for RMB502 Mln

THOMSON REUTERS
·
Aug 28

BAIYUNSHAN PH (00874): Completes Private Fund Registration

Stock News
·
Aug 19

Traditional Medicine Sector Under Pressure as Baiyunshan Faces Performance Challenges

Deep News
·
Aug 19

Baiyunshan Pharma's H1 Profit Slips 1%, Revenue Rises 2%; Hong Kong Shares Up 4%

MT Newswires Live
·
Aug 18

Hong Kong Stock Movement | BAIYUNSHAN PH (00874) Surges Nearly 5% as H1 Net Profit Declines 1.31% YoY While Health Segment Shows Strong Performance

Stock News
·
Aug 18

BAIYUNSHAN PH (00874) Appoints Chen Jiehui as Executive Director of Ninth Board of Directors

Stock News
·
Aug 15

BAIYUNSHAN PH (00874) to Distribute Interim Dividend of HK$0.4399 Per Share on September 26

Stock News
·
Aug 15

Guangzhou Baiyunshan Pharmaceutical - Proposes to Appoint Chen Jiehui as Executive Director of 9TH Session

THOMSON REUTERS
·
Aug 15

BAIYUNSHAN PH (00874) Reports First Half Results with Net Profit of ~2.516 Billion Yuan, Down 1.31% YoY

Stock News
·
Aug 15

Guangzhou Baiyunshan Pharmaceutical - to Pay an Interim Cash Dividend of RMB0.40 per Share

THOMSON REUTERS
·
Aug 15

Guangzhou Baiyunshan Pharmaceutical - Hy Operating Revenue RMB41.83 Bln

THOMSON REUTERS
·
Aug 15

Baiyunshan Pharmaceutical Subsidiary to Issue Medium-Term, Short-Term Securities

MT Newswires Live
·
Jul 28

Guangzhou Baiyunshan Pharmaceutical - Participation in Establishment of Gp Fund Ii

THOMSON REUTERS
·
Jul 25

Baiyunshan Pharmaceutical Gets China Approval for Chest Pain Drug

MT Newswires Live
·
Jul 22

Baiyunshan Pharmaceutical's Vice Chair Steps Down

MT Newswires Live
·
Jun 16